Replies to post #20361 on Relief Therapeutics Holding AG (RLFTF)

[TraderInvictus]

Sorry, yes I meant RLFTF as the front runner. Watching Brady get decimated in this game and lost track of my thoughts.

I wonder if Tampa is regretting their decision yet.

[trademax42]

I believe Relief is well funded for IV trials, inhale formulation trial and the European trial, imo.

This is from the horse's mouth, Chairman Dr. Selvaraju:

There are effectively two trials: For the one we are currently running the total budget will be in the range of CHF 7 to 8 mio. The Inhaled study we just got approval to start will probably cost between CHF 10 and 15 mio......We have already spent close to CHF 4 mio. on the trials, and we currently have close to CHF 3 mio. on our balance sheet.

https://themarket.ch/interview/relief-therapeutics-our-drug-could-generate-hundreds-of-millions-of-dollars-per-year-ld.2478

So the company needs about $25 million to complete both IV and Inhale formulation trials. They already spent $4 million, so they need about $21 million to finish the job. Recently they got about $35 million cash infusion from GEM plus $3 million on their balance sheet, a total of $38 million in hand. Then $38M - $21M = $17 million left to run phase 3 in Europe.

To keep in mind, if the drug gets approval from the FDA in the next couple of months, money will be pouring in into the company coffer.

Quote from your post:

RLFTF certainly now has enough $ to finish the IV trial and at least start the Inhaler trial

$RLFTF

Disclaimer: Just my opinion, do your own dd.

[KDOG9]

Ok holding stock in all 3 and did that intentionally since the drugs can be used in different stages of the disease progression.

I think they all have their place and also will have multiple indications.

Only time and phase 3 results will tell though. Hoping they are all successful.

[IonStock]

Why there's been No News frm Relief Thera in awhile - I found out that there is a "Quiet Period" for publicly-traded companies, which applies to their upcoming Year-End Financial Report that someone on this Board said is Sept. 15th:

{The Quiet Period refers to the time between the end of a financial quarter and the company announcing financial results.

The formal quarter-end Quiet Period begins at the close of each financial quarter and extends until the company’s earnings call; but depending on the management team, this Quiet Period can also include the days leading up to the close of the quarter.

Public companies also enter into Quiet Periods during financings when securities (stock or bonds) are issued to the public. During a financing, the Quiet Period timeline mimics that of an IPO, while the Quiet Period at the end of each financial quarter varies from company to company.}

https://gilmartinir.com/what-is-a-quiet-period/

[Uncle Gee Gee]

Mike Irwin on Twitter is suggesting...” Rlf-100 is the go to therapeutic..next is Brilacidin( late to trials). Love Humanigen.. but Brilacidin complements Rlf 100 in the immune response realm, and adds additional antiviral PLUS antibacterial component! Think Searcy!”